These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8632558

  • 1. Primary chemotherapy in patients with nonseminomatous germ cell tumors of the testis and biological disease only after orchiectomy.
    Culine S, Theodore C, Terrier-Lacombe MJ, Droz JP.
    J Urol; 1996 Apr; 155(4):1296-8. PubMed ID: 8632558
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F, Gleave ME, Coppin CM, Murray N, Sullivan LD.
    Cancer; 1996 Aug 01; 78(3):480-6. PubMed ID: 8697394
    [Abstract] [Full Text] [Related]

  • 4. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D, Borner M, Sonntag RW, Fey MF, Studer UE.
    J Urol; 1999 Apr 01; 161(4):1148-52. PubMed ID: 10081858
    [Abstract] [Full Text] [Related]

  • 5. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB, Nichols CR, Foster RS, Messemer JE, Donohue JP, Einhorn LH.
    J Urol; 1996 Feb 01; 155(2):587-9. PubMed ID: 8558665
    [Abstract] [Full Text] [Related]

  • 6. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD, Patel MI, Sheinfeld J.
    J Urol; 2004 Jan 01; 171(1):168-71. PubMed ID: 14665869
    [Abstract] [Full Text] [Related]

  • 7. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE.
    J Urol; 2008 Jan 01; 179(1):163-6. PubMed ID: 18001800
    [Abstract] [Full Text] [Related]

  • 8. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D, Ondrusova M, Hornak M, Matoska J.
    Neoplasma; 2007 Jan 01; 54(5):437-42. PubMed ID: 17688374
    [Abstract] [Full Text] [Related]

  • 9. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
    Ondrus D, Goncalves F, Kausitz J, Mat'oska J, Belan V.
    Neoplasma; 1996 Jan 01; 43(3):195-7. PubMed ID: 8841507
    [Abstract] [Full Text] [Related]

  • 10. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
    Geldart TR, Gale J, McKendrick J, Kirby J, Mead G.
    BJU Int; 2006 Aug 01; 98(2):353-8. PubMed ID: 16879677
    [Abstract] [Full Text] [Related]

  • 11. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
    Coogan CL, Foster RS, Rowland RG, Bihrle R, Smith ER, Einhorn LH, Roth BJ, Donohue JP.
    Urology; 1997 Dec 01; 50(6):957-62. PubMed ID: 9426730
    [Abstract] [Full Text] [Related]

  • 12. Surgery for testicular cancer: indication, results and technical aspects.
    Khouni H, Ghozzi S, Ramzi K, Smaali CH, Majed H, Ben Rais N.
    Tunis Med; 2005 Dec 01; 83 Suppl 12():78-83. PubMed ID: 16430075
    [Abstract] [Full Text] [Related]

  • 13. A case of spermatic cord teratoma in low-stage testicular cancer managed by surveillance.
    Subramanian VS, Gilligan T, Klein EA.
    Nat Clin Pract Urol; 2008 Apr 01; 5(4):220-3. PubMed ID: 18268549
    [Abstract] [Full Text] [Related]

  • 14. Observations after orchiectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
    Kuo JY, Chin T, Hsieh YL, Lin AT, Chang YH, Wei C, Chen KK, Chang LS.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun 01; 62(6):356-61. PubMed ID: 10389293
    [Abstract] [Full Text] [Related]

  • 15. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P, Siener R, Krege S, Schmelz HU, Dieckmann KP, Heidenreich A, Kwasny P, Pechoel M, Lehmann J, Kliesch S, Köhrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Hartmann M, German Testicular Cancer Study Group.
    J Clin Oncol; 2008 Jun 20; 26(18):2966-72. PubMed ID: 18458040
    [Abstract] [Full Text] [Related]

  • 16. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D, Hornák M, Matoska J, Kausitz J, Belan V, Cársky S.
    Neoplasma; 1993 Jun 20; 40(4):247-53. PubMed ID: 7505886
    [Abstract] [Full Text] [Related]

  • 17. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
    Kondagunta GV, Sheinfeld J, Mazumdar M, Mariani TV, Bajorin D, Bacik J, Bosl GJ, Motzer RJ.
    J Clin Oncol; 2004 Feb 01; 22(3):464-7. PubMed ID: 14752068
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S, Theodore C, Farhat F, Bekradda M, Terrier-Lacombe MJ, Droz JP.
    J Surg Oncol; 1996 Mar 01; 61(3):195-8. PubMed ID: 8637206
    [Abstract] [Full Text] [Related]

  • 19. Drug dose delivery and treatment outcome relationship in standard bleomycin, etoposide and cisplatin combination chemotherapy in nonseminomatous germ cell tumor patients.
    Gutierrez-Delgado F, Titov DA, Tjulandin SA, Garin AM.
    Neoplasma; 1999 Mar 01; 46(3):190-5. PubMed ID: 10613596
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.